Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
OS-060-YI Phase III trials in hepatocellular carcinoma: IMbrave 050 and strategies to address non-proportional hazards
Ezequiel Mauro, Tiago B. R. Castro, Marcus Zeitlhoefler, Allan Hackshaw, MinJae Lee, Tim Meyer, Amit Singal, Josep M. Llovet (2025). OS-060-YI Phase III trials in hepatocellular carcinoma: IMbrave 050 and strategies to address non-proportional hazards. Journal of Hepatology, 82, pp. S45-S45, DOI: 10.1016/s0168-8278(25)00375-7.
Article403 days agoStrategies to address non-proportional hazards between survival curves - Lessons from phase III trials in hepatocellular carcinoma
Ezequiel Mauro, Tiago B. R. Castro, Marcus Zeitlhoefler, Allan Hackshaw, MinJae Lee, Tim Meyer, Amit G. Singal, Josep M. Llovet (2025). Strategies to address non-proportional hazards between survival curves - Lessons from phase III trials in hepatocellular carcinoma. , 84(3), DOI: https://doi.org/10.1016/j.jhep.2025.08.042.
Article89 days agoImmune Checkpoint Inhibitors for Child-Pugh Class B Advanced Hepatocellular Carcinoma
Enrui Xie, Yee Hui Yeo, Bernhard Scheiner, Yue Zhang, Atsushi Hiraoka, Xinxing Tantai, Petros Fessas, Tiago B. R. Castro, Antonio D’Alessio, Claudia Angela Maria Fulgenzi, Shuo Xu, Hong‐Ming Tsai, Swetha Kambhampati, Wenjun Wang, Bridget P. Keenan, Xu Gao, Zixuan Xing, Matthias Pinter, Yih‐Jyh Lin, Zhanjun Guo, Arndt Vogel, Takaaki Tanaka, Hsin‐Yu Kuo, Robin Kate Kelley, Masatoshi Kudo, Ju Dong Yang, David J. Pinato, Fanpu Ji (2023). Immune Checkpoint Inhibitors for Child-Pugh Class B Advanced Hepatocellular Carcinoma. , 9(10), DOI: https://doi.org/10.1001/jamaoncol.2023.3284.
Article65 days ago